Proteintech, the benchmark in antibodies, announces the acquisition of ChromoTek, a manufacturer of Camelid, single-domain antibodies, also known as nanobodies.
You Might Also Like
Study Using NanoString’s GeoMx Digital Spatial Profiler Featured on the Cover of Nature Genetics
Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells
